Hanmi Pharm. Co., Ltd.
Symbol: 128940.KS
KSC
322000
KRWMarktpreis heute
24.3478
P/E-Verhältnis
0.0155
PEG-Verhältnis
4.09T
MRK Kapital
- 0.00%
DIV Rendite
Hanmi Pharm. Co., Ltd. (128940-KS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 254155.7 | 236736.4 | 211734.4 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 199175.4 | 89407.8 | 2509.7 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 179195.9 | 191163.2 | 241982 | ||||||||||||||
balance-sheet.row.inventory | 0 | 288813.8 | 266185.4 | 250188.7 | ||||||||||||||
balance-sheet.row.other-current-assets | 0 | 26487.6 | 73.2 | 56.5 | ||||||||||||||
balance-sheet.row.total-current-assets | 0 | 748652.9 | 694158.3 | 703961.6 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 860242 | 917981.5 | 957218.2 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.long-term-investments | 0 | 47756 | -17742 | 50416.9 | ||||||||||||||
balance-sheet.row.tax-assets | 0 | 159972 | 89901.6 | 91855.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 54367 | 155699.5 | 53106.5 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1203382.2 | 1230427.5 | 1232767.1 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.account-payables | 0 | 45180.3 | 39709.5 | 42833.4 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 483775.4 | 489193 | 455166.9 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 6741.6 | 22180.1 | 26475 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 82028.4 | 225815.6 | 301099.8 | ||||||||||||||
Deferred Revenue Non Current | 0 | 1033.1 | 8457.6 | 10839.7 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0 | 150970.5 | 131195.3 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 146408.2 | 238610.7 | 359531 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 7063.4 | 48215.1 | 65622.2 | ||||||||||||||
balance-sheet.row.total-liab | 0 | 851824.4 | 915359 | 1008469.3 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 0 | 31405.4 | 30794.9 | 30195.7 | ||||||||||||||
balance-sheet.row.retained-earnings | 0 | 336059.3 | 452297.5 | 396915.9 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 216059.6 | 232729.4 | 200479.4 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 371918.2 | 156043.8 | 175322.8 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 955442.4 | 871865.6 | 802913.7 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 144768.3 | 137361.1 | 125345.7 | ||||||||||||||
balance-sheet.row.total-equity | 0 | 1100210.6 | 1009226.7 | 928259.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||
Total Investments | 0 | 246931.4 | 71665.7 | 52926.7 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 572867.3 | 715008.6 | 756266.7 | ||||||||||||||
balance-sheet.row.net-debt | 0 | 517886.9 | 567680 | 547042.1 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 146231.2 | 101558.2 | 81478.2 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 98454 | 96842 | 89086.3 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -57396.6 | -73686.3 | -53516.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | -2602.8 | 38190.1 | -74313.9 | ||||||||||||||
cash-flows.row.inventory | 0 | -16902.6 | -14365.3 | 18915.7 | ||||||||||||||
cash-flows.row.account-payables | 0 | 5574.2 | -2736.1 | 9794.1 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -43465.5 | -94774.9 | -7912.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 29249.1 | 37555 | 84874.8 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 2600.2 | -25772 | -14112.3 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94770.2 | -92923.2 | -7738.6 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 90377.5 | 86.6 | 785.9 | ||||||||||||||
cash-flows.row.other-investing-activites | 0 | -133933.2 | -13206.4 | 12101.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -183472.2 | -181408.1 | -43388.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -103371 | -260971.4 | -232371.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 93.5 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3070.6 | -3834.1 | -4873.5 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | -17995.6 | -5992.2 | -5881.3 | ||||||||||||||
cash-flows.row.other-financing-activites | 0 | -2443 | 233930.9 | 129795.6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -126786.7 | -36866.8 | -113330.6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1372.9 | -5890 | 17863.5 | ||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -92348.3 | -61896 | 63067.3 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 54980.3 | 147328.7 | 209224.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 147328.7 | 209224.6 | 146157.4 | ||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 216537.6 | 162268.9 | 201923.2 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.free-cash-flow | 0 | 168791.1 | 112675.9 | 167498.3 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1490887.5 | 1331546.6 | 1203185.7 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 655030.7 | 612993.5 | 570433.4 | ||||||||||||||
income-statement-row.row.gross-profit | 0 | 835856.7 | 718553.1 | 632752.2 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.operating-expenses | 0 | 610971.8 | 560462.7 | 507336.4 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1266002.5 | 1173456.3 | 1077769.8 | ||||||||||||||
income-statement-row.row.interest-income | 0 | 4617.7 | 7856.4 | 5722.3 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 98454 | 97942.5 | 87056.1 | ||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 0 | 224884.9 | 158090.3 | 125415.9 | ||||||||||||||
income-statement-row.row.income-before-tax | 0 | 195267.6 | 121012.5 | 103696.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 28600.6 | 19454.3 | 22218.3 | ||||||||||||||
income-statement-row.row.net-income | 0 | 146231.2 | 82791.7 | 67025.4 |
Häufig gestellte Frage
Wie hoch ist die Hanmi Pharm. Co., Ltd. (128940.KS) Gesamtvermögen?
Hanmi Pharm. Co., Ltd. (128940.KS) Gesamtvermögen ist 1952035090968.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.671.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 13515.617.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.108.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.158.
Was ist der Hanmi Pharm. Co., Ltd. (128940.KS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 146231157740.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 572867266550.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 610971802715.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.